August 2026

Experience Co posted a modest 2% revenue rise to $129.6 million in FY26, but underlying EBITDA slipped 8% due to weather disruptions, inflationary pressures, and industrial action. The company is advancing a $65 million deal to combine its Skydive business with Inflite Group.

CTI Logistics (ASX:CLX) posted a 69% jump in net profit to $24 million for FY26, driven by robust transport volumes, logistics growth and a $74 million uplift in property valuations. The company also declared a 14 cents per share fully franked dividend.

Web Travel Group has upgraded its first-half FY27 guidance, expecting stronger Total Transaction Value margins, revenue growth, and EBITDA, driven by faster bookings and regional improvements.

NexGen Energy has expanded the vertical reach of its high-grade uranium subdomain at Patterson Corridor East by 94 metres, adding a fifth drill rig to accelerate its 2026 exploration campaign.

Plato Income Maximiser Limited posted a $41.8 million profit for FY26, nearly halving from the previous year, while maintaining its highest monthly dividend rate despite softer market conditions.

Macquarie Technology Group posted a 5.5% revenue rise to $390 million in FY26, extending EBITDA growth to 12 years despite an 8% net profit decline. The company is accelerating data centre expansion with a $240 million land purchase and a $200 million government hybrid investment.

Australian Unity posted a statutory loss of $155.2 million for FY2026, weighed down by regulatory reforms, delayed benefits from investments, and significant non-cash asset impairments. The mutual is advancing its climate risk management and has laid out a growth-focused strategy for FY2027.

Botanix Pharmaceuticals posted a 487% jump in revenue to $33.8 million for FY26, driven by Sofdra's first full year of US sales and royalties from Asia. Despite a $69.8 million net loss, the company narrowed losses by nearly 20% amid commercial expansion and strategic cost management.

Invion Limited narrowed its FY26 loss by 36% to $5.63 million while advancing its PhotosoftTM technology with a perpetual global license, FDA orphan drug designation, and new clinical collaborations.

Nido Education lifted group revenue by 4% to $85.8 million in the first half of 2026 but saw adjusted EBITDA and net profit halve. The company withdrew its FY26 EBITDA growth guidance due to softer trading conditions, despite strong enrolment enquiries and ongoing acquisitions.

Mayfield Group Holdings has lifted its fully franked final dividend to 2.4 cents per share for FY2026, reflecting ongoing confidence in its financial position and shareholder returns.

NoviqTech has terminated its planned divestment of key software assets after the ASX indicated potential listing conditions that the company cannot meet. The move leaves the company’s share reinstatement uncertain as discussions with the exchange continue.

Neurotech International has accelerated its lead drug NTI164 into a pivotal Phase 3 trial for Autism Spectrum Disorder, reducing its annual loss by 38% and securing $3.75 million in new funding.

Nova Eye Medical reported a 19% rise in revenues to AUD 34.9 million for FY26, alongside a 52% reduction in net loss to AUD 4.3 million, reflecting improved sales and cost controls.

Infragreen Group Limited (ASX:IFN) reported a robust FY26 with underlying EBITDA up 29% to $23.9 million and a statutory net profit of $7.6 million, reversing prior losses. The company declared fully franked dividends and outlined a confident outlook for FY27 with EBITDA guidance of $26-28 million.

Argenica Therapeutics lifted revenue by 53% to $5.7 million in FY2026, slashing its loss by 81% as it progresses its neuroprotective stroke drug xaranetide through clinical and regulatory milestones.

Acrow Limited secures final ACCC approval for its AusGroup Industrial Services acquisition, clearing the path for completion on 1 September 2026 and strengthening its foothold in Australia’s civil infrastructure sector.

Hawsons Iron has completed a Preliminary Feasibility Study confirming a 2.3 billion tonne Ore Reserve and outlined a 26-year mine plan, while raising over AUD 7 million through share placements and plans. The company faces going concern uncertainty but is progressing funding talks including a non-binding EOI from KfW IPEX.

Academies Australasia Group posted a 6.9% drop in FY26 revenue alongside an 11% increase in net loss, despite a 27% improvement in operating cash flow and reduced expenses.

H&G High Conviction Limited slashed its net loss to $63,137 for FY2026 after divesting its investment portfolio, holding only cash and planning a recapitalisation placement to regain ASX listing.

Bathurst Resources delivered a consolidated EBITDA of NZD 44.7 million for FY26, reaching the top of its guidance despite a challenging start to the year for export coal prices. The company advanced key growth projects in New Zealand and Canada while maintaining a robust cash position.

Pure Foods Tasmania has issued 15 million shares through a placement, debt conversion, and employee remuneration, raising $257,000 and extinguishing $58,000 of debt, all at a discount to recent market prices.

CurveBeam AI (ASX:CVB) secured shareholder approval for a $5 million placement and is closing its Share Purchase Plan on 28 August, positioning the company to capitalise on upcoming commercial milestones with Wego Orthopaedics in China.

Estrella Resources (ASX: ESR) denies any undisclosed material information following a recent uptick in its share price and volume, confirming ongoing exploration activities and compliance with ASX rules.